Trafalgar International (GCAN) Accounts Payables (2017 - 2026)
Trafalgar International (GCAN) posted Accounts Payables of $7514.0 for Q1 2026, down 11.75% on a QoQ basis from $8514.0 in Q4 2025, and down 6.59% year-over-year from $8044.0 in Q1 2025.
Analysis
Trafalgar International (GCAN) Accounts Payables (2017 - 2026) Analysis & Trends
Trafalgar International has reported Accounts Payables for 10 years, with the latest figure at $7514.0 in Q1 2026.
- On a quarterly basis, Accounts Payables fell 6.59% year-over-year to $7514.0 in Q1 2026; TTM through Mar 2026 was $7514.0, a 6.59% decrease from a year earlier, with the FY2025 full-year figure at $8514.0, up 8.06% from the prior year.
- Accounts Payables was $7514.0 for Q1 2026 at Trafalgar International, down from $8514.0 in the prior quarter.
- The five-year high for Accounts Payables was $16251.0 in Q4 2022, with the low at $3340.0 in Q3 2023.
- Average Accounts Payables over 5 years is $8126.2, with a median of $7514.0 recorded in 2026.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables soared 333.56% in 2022, then sank 76.64% in 2023.
- Over 5 years, Accounts Payables stood at $16251.0 in 2022, then plunged by 62.5% to $6094.0 in 2023, then rose by 29.29% to $7879.0 in 2024, then rose by 8.06% to $8514.0 in 2025, then dropped by 11.75% to $7514.0 in 2026.
- The last three Accounts Payables figures came in at $7514.0 (Q1 2026), $8514.0 (Q4 2025), and $8849.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 4.58 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 7,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7,514.00 |
| Dec 31, 2025 | 8,514.00 |
| Sep 30, 2025 | 8,849.00 |
| Jun 30, 2025 | 6,793.00 |
| Mar 31, 2025 | 8,044.00 |
| Dec 31, 2024 | 7,879.00 |
| Sep 30, 2024 | 6,418.00 |
| Jun 30, 2024 | 5,259.00 |
| Mar 31, 2024 | 6,259.00 |
| Dec 31, 2023 | 6,094.00 |
| Sep 30, 2023 | 3,340.00 |
| Jun 30, 2023 | 5,340.00 |
| Mar 31, 2023 | 5,993.00 |
| Dec 31, 2022 | 16,251.00 |
| Sep 30, 2022 | 14,297.00 |
| Jun 30, 2022 | 8,346.00 |
| Mar 31, 2022 | 12,955.00 |
| Dec 31, 2021 | 11,705.00 |
| Sep 30, 2021 | 8,442.00 |
| Jun 30, 2021 | 1,925.00 |